Comparative Pharmacokinetics of Intranasal or Intramuscular Atipamezole in Unsedated Dogs and Efficacy for Reversal of Xylazine Sedation
Journal of Veterinary Pharmacology and Therapeutics · 2026
DOI: 10.1111/jvp.70045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2026. Verfasst von Vanessa E Cowan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Biomedical Sciences, Western College of Veterinary Medicine, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Adrenergic alpha-2 Receptor Antagonists, Hypnotics and Sedatives, Imidazoles, Xylazine. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Western College of Veterinary Medicine, University of Saskatchewan.
Abstract (Originalsprache)
The objectives of this study were to evaluate ATIP pharmacokinetics (PK) in healthy Beagle dogs after IM and IN dosing (Phase I), and to compare the rate of reversal of IM versus IN routes for xylazine (XYL) sedation (Phase II). This study was comprised of two sequential, randomized, crossover experiments. The initial PK study dosed ATIP by IN and IM routes without XYL sedation. In the second phase, dogs were sedated with XYL prior to ATIP reversal. Their sedation scores were monitored during this period, and blood sampling began 20 min post reversal. ATIP was quantified in plasma using a validated HPLC–MS/MS method. Plasma concentrations of ATIP rapidly increased and declined after both routes, but C max and AUC were higher after IM dosing ( p < 0.001). Relative IN bioavailability was 33%–50% of the IM dose. Xylazine reversal of sedation was more rapid after IM versus IN ATIP ( p < 0.01), but both routes produced complete reversal within 40 min. In conclusion, IN ATIP was slower than IM for reversing XYL sedation but is a viable route if parenteral administration is not an option. Adjusting the labeled IM ATIP dose may be warranted for IN use to account for lower bioavailability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Veterinary Biomedical Sciences, Western College of Veterinary Medicine, Saskatoon, Saskatchewan, Canada.
- College of Pharmacy and Nutrition, University of Saskatoon, Saskatoon, Saskatchewan, Canada.
- Animal and Poultry Science, College of Agriculture and Bioresources, University of Saskatoon, Saskatoon, Saskatchewan, Canada.
- Small Animal Clinical Sciences, Western College of Veterinary Medicine, Saskatoon, Saskatchewan, Canada.
ORCID-Profile: Vanessa E Cowan, Jennifer M Loewen, Alan L Chicoine
Förderung
- Western College of Veterinary Medicine, University of Saskatchewan
Zitieren
APA
Cowan, V. E., Mitcham, V. R., Michel, D. L., Lyons, C., Kennedy, J., Reyes Morales, Y. C., Loewen, J. M., & Chicoine, A. L. (2026). Comparative Pharmacokinetics of Intranasal or Intramuscular Atipamezole in Unsedated Dogs and Efficacy for Reversal of Xylazine Sedation. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70045
Vancouver
Cowan VE, Mitcham VR, Michel DL, Lyons C, Kennedy J, Reyes Morales YC, et al. Comparative Pharmacokinetics of Intranasal or Intramuscular Atipamezole in Unsedated Dogs and Efficacy for Reversal of Xylazine Sedation. Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70045
BibTeX
@article{Cowan2026,
author = {Cowan, Vanessa E and Mitcham, Vanessa R and Michel, Deborah L and Lyons, Chloe and Kennedy, Juliet and Reyes Morales, Yoana C and Loewen, Jennifer M and Chicoine, Alan L},
title = {Comparative Pharmacokinetics of Intranasal or Intramuscular Atipamezole in Unsedated Dogs and Efficacy for Reversal of Xylazine Sedation},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/jvp.70045}
}
EUVIMED